Search

everythinglearnresearchcommunity

for

Search:↓

Vismodegib can cause muscle spasms, taste changes, hair loss, fatigue, weight loss, and possibly new issues like skin cancer, dehydration, and swallowing problems, needing close monitoring.

Stopping gefitinib improved scalp condition in a woman with lung cancer.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

Tofacitinib might be used to treat hair loss.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Tofacitinib significantly improved skin and hair conditions without side effects.

Deucravacitinib helped a man regrow hair significantly.

BRAF inhibitors for melanoma often cause skin side effects, but they can be managed with proper care.

CVP therapy showed moderate success in treating advanced non-Hodgkin's lymphoma, but more intensive treatment is needed for better outcomes.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

The drug combination was safe and showed promise in treating advanced tumors.

Ivarmacitinib effectively regrows hair in severe alopecia areata.

Selumetinib causes fewer and less severe skin issues in children than binimetinib.

Targeted therapy with Ustekinumab significantly improved a skin condition called ILVEN, which is caused by mutations in the CARD14 gene.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

Tofacitinib taken by mouth helps treat hair loss in children.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

Sunlight exposure improved a patient's skin condition, and there may be a link between a certain disease and skin growths; a leukemia treatment caused changes in hair color and growth.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

Deucravacitinib helped regrow hair and reduce plaques in a woman with discoid lupus erythematosus without side effects.

Janus kinase inhibitors may help treat cutaneous T-cell lymphoma, but more research is needed.

Combining DEB-BACE with chemotherapy is more effective and has fewer side effects than chemotherapy alone for treating unresectable lung squamous cell carcinoma.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

A rare skin reaction from cancer treatment was successfully managed with topical treatments and antihistamines.

Low-dose sorafenib can cause severe facial acne, treatable with topical medication.

Photodynamic therapy improved skin issues from sorafenib when other treatments failed.